Cargando…
Molecular investigations on Candida glabrata clinical isolates for pharmacological targeting
Prevalence of drug resistant C. glabrata strains in hospitalized immune-compromised patients with invasive fungal infections has increased at an unexpected pace. This has greatly pushed researchers in identification of mutations/variations in clinical isolates for better assessment of the prevailing...
Autores principales: | Gupta, Hrishikesh, Gupta, Payal, Kairamkonda, Manikyaprabhu, Poluri, Krishna Mohan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194923/ https://www.ncbi.nlm.nih.gov/pubmed/35765448 http://dx.doi.org/10.1039/d2ra02092k |
Ejemplares similares
-
Elucidating the Eradication Mechanism of Perillyl
Alcohol against Candida glabrata Biofilms: Insights
into the Synergistic Effect with Azole Drugs
por: Gupta, Payal, et al.
Publicado: (2021) -
Effectiveness of Phytoactive Molecules on Transcriptional
Expression, Biofilm Matrix, and Cell Wall Components of Candida glabrata and Its Clinical Isolates
por: Gupta, Payal, et al.
Publicado: (2018) -
Occurrence of killer Candida glabrata clinical isolates
por: Arroyo-Helguera, O, et al.
Publicado: (2012) -
Diversity and antifungal susceptibility of Norwegian Candida glabrata clinical isolates
por: Andersen, Kari-Mette, et al.
Publicado: (2016) -
Comparative Genomics of Two Sequential Candida glabrata Clinical Isolates
por: Vale-Silva, Luis, et al.
Publicado: (2017)